CRESS UMR 1153
CRESS UMR 1153 is a French public research institution conducting epidemiological and statistical research across five teams—nutritional, perinatal, methodological, musculoskeletal, and aging epidemiology—serving public health policy through academic and government partnerships.
- Company typePrivate
- Founded2014
- HeadquartersParis, France
- Headcount11–50
- GTM typeB2B
- OfferingServices
What CRESS UMR 1153 does
CRESS UMR 1153 (Centre de Recherche en Epidémiologie et Statistiques) is a French public research unit established in 2014 and jointly affiliated with Inserm, Université Paris Cité, Université Sorbonne Paris Nord, and INRAE. The center conducts epidemiological and statistical research across five teams: OPPaLE (perinatal, pediatric, and environmental epidemiology), METHODS (statistical methods and meta-research), ECAMO (clinical epidemiology of musculoskeletal diseases), EpiAgeing (epidemiology of aging and neurodegenerative diseases), and EREN (nutritional epidemiology). It studies determinants of population health across the life course and designs and evaluates interventions to improve clinical practices and public health policy.
The center's core research infrastructure centers on the NutriNet-Santé web-cohort, launched in 2009 with over 174,000 volunteers aged 15 and older, which functions as a longitudinal research platform for nutritional epidemiology. CRESS is the creator of Nutri-Score, a front-of-pack nutritional labeling system now official in France and six other European countries. The center coordinates the NACRe network of 43 French academic laboratories and 10 European institutions working on nutrition and cancer, and maintains international research collaborations with IARC-WHO, Imperial College London, the Global Burden of Disease network, the University of São Paulo, the University of North Carolina, and Deakin University. Methodological outputs include pediatric growth monitoring algorithms, fitness tool indices for long-term disability/mortality prediction, and sleep–wake cycle biomarkers for neurocognitive disease risk.
CRESS is a non-profit public research institution with no commercial revenue model. It is funded through government research allocations from its parent institutions, competitive public grants (ANR, INCa, ERC, Horizon Europe), and institutional partnerships with agencies such as Santé Publique France. The center has approximately 325 personnel, including 110+ tenured researchers and teacher-researchers, 120+ engineers, technicians, and administrative staff, and 95+ PhD students and postdoctoral researchers. Research outputs are disseminated through peer-reviewed publications, scientific conferences, public engagement, and policy consultations with national health authorities; the center has no commercial product, API, or paying customer base.
CRESS UMR 1153 firmographics
Firmographics- Name
- CRESS UMR 1153
- Legal name
- Centre de Recherche en Epidémiologie et Statistiques (CRESS)
- Website
- https://cress-umr1153.fr
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- CRESS UMR 1153 is a French public research institution conducting epidemiological and statistical research across five teams—nutritional, perinatal, methodological, musculoskeletal, and aging epidemiology—serving public health policy through academic and government partnerships.
- Ownership category
- akta.pro rank
CRESS UMR 1153 industry classification
Industry- Product category
- Public Health Research
- NAICS
- Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Health Services (8000)
- akta.pro primary industry
- Real-World Evidence (RWE), HEOR & Epidemiology CROs (HLAGAAAK)
- akta.pro secondary industry
- Clinical Data Management, Biostatistics & Statistical Programming CROs (HLAGAAAF)
Keywords
Where CRESS UMR 1153 is headquartered
LocationHeadquarters
- HQ city
- Paris
- HQ country
- France
- HQ region
- Europe
Offices4 records
Markets served
CRESS UMR 1153 business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Infrastructure
Revenue model
- Public Research Funding: CRESS is a public research unit (UMR) affiliated with Inserm, Université Paris Cité, Université Sorbonne Paris Nord, and INRAE. Funding is derived from government research allocations, institutional partnerships, and competitive public research grants.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels6 records
CRESS UMR 1153 product offering
Product offeringCore offering
CRESS UMR 1153 is a public research center that conducts epidemiological and statistical research across five teams (OPPaLE, METHODS, ECAMO, EpiAgeing, EREN). It studies population health determinants across the lifespan, develops innovative research methodologies, and designs and evaluates interventions to improve clinical practices and public health policies. The center operates large-scale research infrastructures including the NutriNet-Santé web-cohort with over 174,000 volunteers.
Product overview
CRESS UMR 1153 (Centre de Recherche en Epidémiologie et Statistiques) is a French public health research institution comprising five research teams: OPPaLE (perinatal, pediatric, and environmental epidemiology), METHODS (methodology and meta-research), ECAMO (musculoskeletal disease epidemiology), EpiAgeing (aging and neurodegenerative disease epidemiology), and EREN (nutritional epidemiology). The center operates major research infrastructure including the NutriNet-Santé web-cohort with over 174,000 volunteers, and develops methodological tools such as child growth monitoring algorithms. CRESS conducts population health research, creates epidemiological methodologies, and evaluates interventions to improve clinical practices and public health policies. No commercial product or API offering exists.
Differentiator
Problem solved
Functional benefit
Brands
- NutriNet-Santé: Web-cohort study coordinated by EREN team, launched in 2009 with over 174,000 volunteers.
- EREN
- OPPaLE
- METHODS
- ECAMO
- EpiAgeing
- SMART
Products and services
- NutriNet-Santé Cohort
- EREN - Equipe de Recherche en Epidémiologie Nutritionnelle
Quantifiable outcome
- Nutri-Score adopted as official labeling system in France and 6 other European countries
- +1 more outcomes
Companies that use CRESS UMR 1153
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
CRESS UMR 1153 technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
CRESS UMR 1153 partnerships and signals
Strategic signalPartnerships
Twelve partnerships are on record, tiered core and major.
- Santé Publique France (ESEN)corePartnership with Santé Publique France through the ESEN (Equipe de Surveillance en Epidémiologie Nutritionnelle) team integrated into EREN under a mixed-agreement convention, focusing on public health nutritional surveillance.
- IARC-WHO (International Agency for Research on Cancer)coreInternational collaboration on cancer research and nutritional epidemiology, working with the World Health Organization's cancer research agency.
- Imperial College LondoncoreAcademic research collaboration on nutritional epidemiology and public health research with one of the world's leading universities.
- University of São PaulomajorInternational academic partnership for nutritional epidemiology research collaboration.
- University of North CarolinamajorInternational research collaboration in epidemiology and public health.
- Global Burden of Disease Network (University of Washington)coreCollaboration with the Global Burden of Disease study network for international health burden research.
- Deakin University (Sydney, Australia)majorInternational academic partnership for nutrition and public health research.
- NACRe Network (Nutrition Activité physique Cancer Recherche)coreEREN coordinates the NACRe network comprising 43 French academic laboratories and 10 European institutions working on nutrition and cancer research, funded by INCa.
- InsermcorePrimary institutional affiliation; Inserm is the national institute for health and medical research in France.
- Université Paris CitécorePrimary university affiliation for research and teaching activities.
- Université Sorbonne Paris NordcoreUniversity affiliation for research activities.
- INRAEcoreInstitutional affiliation with the French National Research Institute for Agriculture, Food and Environment.
Scale indicators4 records
Recent moves7 records
Expansion highlights5 records
CRESS UMR 1153 competitors and assessment
Company assessmentBroad incumbents
- Erasmus MC: A major Dutch academic medical center with extensive epidemiology and population health research. Erasmus MC's cohort-based research and methodological expertise align with CRESS's core activities.
- INRAE: Co-affiliating institution of CRESS and France's national research institute for agriculture, food, and environment. INRAE operates across nutrition and food science domains, with substantial overlap on nutritional epidemiology research that CRESS focuses on.
- Inserm: Parent institution of CRESS and the French national institute for health and medical research. Inserm covers the full breadth of biomedical research across France, while CRESS is a specialized epidemiology unit within it, making Inserm both a parent and a broad institutional peer.
- Karolinska Institutet: Sweden's leading medical university with substantial epidemiology and public health research programs. Karolinska has cohort studies and aging research that overlap with CRESS's EpiAgeing and EREN focus areas.
- Harvard T.H. Chan School of Public Health: A leading global public health research institution with deep expertise in epidemiology, nutrition, and aging research. While much larger and broader than CRESS, it operates in the same research domains and competes for the same scientific talent and grant funding.
- University College London (UCL) Institute of Epidemiology and Health Care: A leading UK-based epidemiology research institution with strengths in life-course epidemiology and aging research. UCL's research portfolio overlaps with CRESS's EpiAgeing team and broader methodology work.
Direct peers
- Santé Publique France: France's national public health agency and a core partner of CRESS through the ESEN team. It conducts national health surveillance and nutritional epidemiology, directly overlapping with CRESS's mission and serving as both a research partner and functional peer.
- London School of Hygiene & Tropical Medicine: A leading European public health research institution with strengths in epidemiology, nutrition, and population health. LSHTM's research focus and large cohort studies make it a direct international peer to CRESS's epidemiological research.
- Imperial College London School of Public Health: One of CRESS's named international collaboration partners, with overlapping research in nutritional epidemiology, life-course epidemiology, and population health methodology. Imperial's scale and global reach make it a strong international peer.
- University of Washington Institute for Health Metrics and Evaluation (IHME): A named CRESS collaboration partner and the coordinator of the Global Burden of Disease study. IHME's focus on global health metrics, epidemiology methods, and policy translation directly overlaps with CRESS's population health research and policy advisory role.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
CRESS UMR 1153 social profiles
Digital presenceCRESS UMR 1153 financial estimates
Financial estimateRevenue estimate
Valuation estimate
CRESS UMR 1153 leadership team
Management profileNumber of profiles
Profiles7 records
CRESS UMR 1153 funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CRESS UMR 1153 M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CRESS UMR 1153
What does CRESS UMR 1153 do?
CRESS UMR 1153 is a public research center that conducts epidemiological and statistical research across five teams (OPPaLE, METHODS, ECAMO, EpiAgeing, EREN). It studies population health determinants across the lifespan, develops innovative research methodologies, and designs and evaluates interventions to improve clinical practices and public health policies. The center operates large-scale research infrastructures including the NutriNet-Santé web-cohort with over 174,000 volunteers.
Is CRESS UMR 1153 a public or private company?
CRESS UMR 1153 is a private company. It is classified as state government owned and is currently operating.
When was CRESS UMR 1153 founded?
CRESS UMR 1153 was founded in 2014. It employs 11 to 50 people.
Where is CRESS UMR 1153 based?
CRESS UMR 1153 is headquartered in Paris, France, in the Europe region.
How does CRESS UMR 1153 make money?
One revenue line is on record: public Research Funding.
Who are CRESS UMR 1153's main competitors?
Broad incumbents on record are Erasmus MC, INRAE, Inserm, Karolinska Institutet, Harvard T.H. Chan School of Public Health and University College London (UCL) Institute of Epidemiology and Health Care. Direct peers are Santé Publique France, London School of Hygiene & Tropical Medicine, Imperial College London School of Public Health and University of Washington Institute for Health Metrics and Evaluation (IHME).
Does CRESS UMR 1153 have an API?
No public API is recorded for CRESS UMR 1153.
What industry is CRESS UMR 1153 in?
CRESS UMR 1153's product category is Public Health Research. Its primary akta.pro industry code is HLAGAAAK, Real-World Evidence (RWE), HEOR & Epidemiology CROs, with a secondary code of HLAGAAAF, Clinical Data Management, Biostatistics & Statistical Programming CROs. Its NAICS code is 5417 and its SIC code is 8731.